Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
5CV.DE Stock Summary
Top 10 Correlated ETFs
5CV.DE
In the News
5CV.DE Financial details
Company Rating
Neutral
Market Cap
640.31M
Income
-302.3M
Revenue
42.88M
Book val./share
2.69
Cash/share
2.09
Dividend
-
Dividend %
-
Employees
904
Optionable
No
Shortable
Yes
Earnings
24 Apr 2024
P/E
-2.7
Forward P/E
-3.43
PEG
0.81
P/S
20.08
P/B
1.36
P/C
1.36
P/FCF
-2.57
Quick Ratio
3.25
Current Ratio
3.56
Debt / Equity
0.07
LT Debt / Equity
0.06
-
-
EPS (TTM)
-1.47
EPS next Y
-0.83
EPS next Q
-0.19
EPS this Y
-40.27%
EPS next Y
-43.43%
EPS next 5Y
-49.66%
EPS last 5Y
26.97%
Revenue last 5Y
39.26%
Revenue Q/Q
117.48%
EPS Q/Q
-26.67%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-40%
Inst Own
-
Inst Trans
-
ROA
-36%
ROE
-48%
ROC
-0.44%
Gross Margin
-252%
Oper. Margin
-718%
Profit Margin
-705%
Payout
-
Shs Outstand
223.88M
Shs Float
91.6M
-
-
-
-
Target Price
-
52W Range
2.53-11.28
52W High
-74.09%
52W Low
+42.5%
RSI
42
Rel Volume
0.62
Avg Volume
87.1K
Volume
54.04K
Perf Week
2.15%
Perf Month
-10.38%
Perf Quarter
-50.69%
Perf Half Y
-59.05%
-
-
-
-
Beta
2.531
-
-
Volatility
0.04%, 0.16%
Prev Close
0%
Price
2.85
Change
1.79%
5CV.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.07 | 0.1 | 0.27 | 0.55 | 0.36 | |
Net income per share | -0.4 | -0.57 | -0.72 | -2.21 | -1.32 | |
Operating cash flow per share | -0.42 | -0.49 | 2.89 | -3.94 | -1.51 | |
Free cash flow per share | -0.5 | -0.56 | 2.63 | -4.63 | -2.01 | |
Cash per share | 0.34 | 0.18 | 7.34 | 4.39 | 2.65 | |
Book value per share | 0.18 | -0.24 | 3.94 | 3.7 | 2.82 | |
Tangible book value per share | 0.15 | -0.28 | 3.86 | 3.63 | 2.65 | |
Share holders equity per share | 0.18 | -0.24 | 3.94 | 3.7 | 2.82 | |
Interest debt per share | 0 | 0.46 | 0.29 | 0.21 | 0.24 | |
Market cap | 7.14B | 7.14B | 13.23B | 5.62B | 1.07B | |
Enterprise value | 7.12B | 7.19B | 11.94B | 4.83B | 616.45M | |
P/E ratio | -100.23 | -71.5 | -102.51 | -13.64 | -4.3 | |
Price to sales ratio | 554.8 | 410.01 | 270.58 | 54.53 | 15.87 | |
POCF ratio | -96.35 | -82.11 | 25.33 | -7.66 | -3.74 | |
PFCF ratio | -80.38 | -71.99 | 27.85 | -6.52 | -2.82 | |
P/B Ratio | 222.57 | -166.83 | 18.6 | 8.16 | 2.01 | |
PTB ratio | 222.57 | -166.83 | 18.6 | 8.16 | 2.01 | |
EV to sales | 553.14 | 412.8 | 244.15 | 46.93 | 9.14 | |
Enterprise value over EBITDA | -106.14 | -78.57 | -108.73 | -12.51 | -2.76 | |
EV to operating cash flow | -96.07 | -82.67 | 22.85 | -6.59 | -2.15 | |
EV to free cash flow | -80.14 | -72.48 | 25.13 | -5.61 | -1.62 | |
Earnings yield | -0.01 | -0.01 | -0.01 | -0.07 | -0.23 | |
Free cash flow yield | -0.01 | -0.01 | 0.04 | -0.15 | -0.35 | |
Debt to equity | 0.01 | -1.85 | 0.04 | 0.04 | 0.08 | |
Debt to assets | 0 | 0.61 | 0.02 | 0.02 | 0.05 | |
Net debt to EBITDA | 0.32 | -0.53 | 11.77 | 2.02 | 2.03 | |
Current ratio | 2.6 | 2.04 | 5.61 | 2.63 | 3.74 | |
Interest coverage | -264.81 | -68.15 | -5.61 | -39.88 | -67.29 | |
Income quality | 1.04 | 0.87 | -4.02 | 1.78 | 1.15 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 1.59 | 2.42 | 0.92 | 0.85 | 1.32 | |
Research and developement to revenue | 3.24 | 2.48 | 2.33 | 7.92 | 0.93 | |
Intangibles to total assets | 0.05 | 0.04 | 0.01 | 0.01 | 0.04 | |
Capex to operating cash flow | 0.2 | 0.14 | -0.09 | 0.17 | 0.33 | |
Capex to revenue | -1.14 | -0.7 | -0.97 | -1.24 | -1.38 | |
Capex to depreciation | -3.89 | -1.71 | -4.44 | -8.16 | -3.93 | |
Stock based compensation to revenue | -0.33 | 1.12 | 0.29 | 0.15 | 0.14 | |
Graham number | 1.29 | 1.76 | 7.96 | 13.58 | 9.14 | |
ROIC | -2.26 | -1.97 | -0.16 | -0.55 | -0.4 | |
Return on tangible assets | -0.6 | -0.8 | -0.09 | -0.36 | -0.3 | |
Graham Net | -0.15 | -0.71 | 2.96 | 2.09 | 1.14 | |
Working capital | 44.94M | 29.09M | 1.14B | 582.29M | 427.8M | |
Tangible asset value | 25.87M | -48.5M | 697.2M | 675.24M | 501.48M | |
Net current asset value | -20.51M | -116.25M | 589.85M | 470.25M | 256.81M | |
Invested capital | 0.01 | -1.85 | 0.04 | 0.04 | 0.08 | |
Average receivables | 0 | 12.27M | 9.75M | 10.16M | 28.97M | |
Average payables | 0 | 7.18M | 11.48M | 69.94M | 95.25M | |
Average inventory | 0 | 4.57M | 10.36M | 35.35M | 40.07M | |
Days sales outstanding | 194.48 | 370.66 | 13.6 | 65.58 | 213.5 | |
Days payables outstanding | 185.73 | 69.54 | 453.85 | 187.35 | 135.38 | |
Days of inventory on hand | 60.7 | 80.83 | 374.22 | 86.06 | 47.59 | |
Receivables turnover | 1.88 | 0.98 | 26.84 | 5.57 | 1.71 | |
Payables turnover | 1.97 | 5.25 | 0.8 | 1.95 | 2.7 | |
Inventory turnover | 6.01 | 4.52 | 0.98 | 4.24 | 7.67 | |
ROE | -2.22 | 2.33 | -0.18 | -0.6 | -0.47 | |
Capex per share | -0.08 | -0.07 | -0.26 | -0.69 | -0.49 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.06 | 0.06 | 0.03 | 0.03 | 0.07 | |
Net income per share | -0.26 | -0.68 | -0.27 | -0.3 | -0.22 | |
Operating cash flow per share | -0.2 | -0.26 | -0.47 | -0.29 | -0.27 | |
Free cash flow per share | -0.35 | -0.37 | -0.53 | -0.35 | -0.33 | |
Cash per share | 2.95 | 2.65 | 2.93 | 2.43 | 2.09 | |
Book value per share | 3.4 | 2.82 | 3.37 | 2.9 | 2.69 | |
Tangible book value per share | 3.21 | 2.65 | 3.23 | 2.76 | 2.55 | |
Share holders equity per share | 3.4 | 2.82 | 3.37 | 2.9 | 2.69 | |
Interest debt per share | 0.23 | 0.23 | 0.2 | 0.19 | 0.21 | |
Market cap | 1.53B | 1.07B | 1.36B | 2.14B | 1.45B | |
Enterprise value | 1.03B | 616.45M | 785.33M | 1.65B | 1.02B | |
P/E ratio | -8.06 | -2.08 | -5.93 | -7.95 | -7.43 | |
Price to sales ratio | 136.77 | 91.55 | 191.01 | 282.7 | 87.76 | |
POCF ratio | -42.69 | -21.8 | -13.67 | -33.42 | -23.88 | |
PFCF ratio | -24.05 | -15.34 | -12.08 | -27.36 | -19.55 | |
P/B Ratio | 2.45 | 2.01 | 1.91 | 3.3 | 2.4 | |
PTB ratio | 2.45 | 2.01 | 1.91 | 3.3 | 2.4 | |
EV to sales | 92.21 | 52.74 | 110.16 | 217.06 | 62.15 | |
Enterprise value over EBITDA | -25.59 | -4.88 | -15.42 | -27.35 | -26.16 | |
EV to operating cash flow | -28.78 | -12.56 | -7.89 | -25.66 | -16.91 | |
EV to free cash flow | -16.21 | -8.84 | -6.97 | -21 | -13.84 | |
Earnings yield | -0.03 | -0.12 | -0.04 | -0.03 | -0.03 | |
Free cash flow yield | -0.04 | -0.07 | -0.08 | -0.04 | -0.05 | |
Debt to equity | 0.07 | 0.08 | 0.06 | 0.06 | 0.07 | |
Debt to assets | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 | |
Net debt to EBITDA | 12.36 | 3.59 | 11.32 | 8.27 | 10.78 | |
Current ratio | 3.61 | 3.74 | 7.61 | 3.86 | 3.56 | |
Interest coverage | -96.64 | -192.87 | -63.46 | -40.27 | -13.23 | |
Income quality | 0.75 | 0.38 | 1.73 | 0.95 | 1.24 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 1.96 | 2.02 | 2.75 | 2.5 | 0.96 | |
Research and developement to revenue | 1.12 | 2.36 | 3.4 | 4.07 | 1.65 | |
Intangibles to total assets | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | |
Capex to operating cash flow | 0.78 | 0.42 | 0.13 | 0.22 | 0.22 | |
Capex to revenue | -2.48 | -1.77 | -1.85 | -1.87 | -0.81 | |
Capex to depreciation | -4.16 | -52.71 | -2.25 | -2.52 | -2.27 | |
Stock based compensation to revenue | 0.25 | 0.23 | 0.22 | 0.4 | 0.1 | |
Graham number | 4.44 | 6.57 | 4.54 | 4.43 | 3.63 | |
ROIC | -0.07 | -0.2 | -0.08 | -0.1 | -0.08 | |
Return on tangible assets | -0.05 | -0.16 | -0.06 | -0.08 | -0.06 | |
Graham Net | 1.45 | 1.14 | 1.78 | 1.41 | 1.14 | |
Working capital | 449.93M | 427.8M | 596.62M | 446.93M | 386.15M | |
Tangible asset value | 591.21M | 501.48M | 682.8M | 617.35M | 571.8M | |
Net current asset value | 336.76M | 256.81M | 426.64M | 352.78M | 296.53M | |
Invested capital | 0.07 | 0.08 | 0.06 | 0.06 | 0.07 | |
Average receivables | 9.76M | 22.8M | 22.64M | 10.87M | 18.83M | |
Average payables | 50.55M | 60.43M | 41.61M | 14.2M | 12.99M | |
Average inventory | 10.55M | 15.93M | 24.33M | 23.44M | 22.75M | |
Days sales outstanding | 49.53 | 303.65 | 73.76 | 188.87 | 118.76 | |
Days payables outstanding | 196.63 | 76.78 | 65.31 | 46.71 | 46.59 | |
Days of inventory on hand | 29.41 | 26.99 | 107.63 | 77.26 | 86.36 | |
Receivables turnover | 1.82 | 0.3 | 1.22 | 0.48 | 0.76 | |
Payables turnover | 0.46 | 1.17 | 1.38 | 1.93 | 1.93 | |
Inventory turnover | 3.06 | 3.33 | 0.84 | 1.16 | 1.04 | |
ROE | -0.08 | -0.24 | -0.08 | -0.1 | -0.08 | |
Capex per share | -0.15 | -0.11 | -0.06 | -0.06 | -0.06 |
5CV.DE Frequently Asked Questions
What is CureVac N.V. stock symbol ?
CureVac N.V. is a DE stock and trading under the symbol 5CV.DE
What is CureVac N.V. stock quote today ?
CureVac N.V. stock price is $2.85 today.
Is CureVac N.V. stock public?
Yes, CureVac N.V. is a publicly traded company.